Part 1 of 3.
My guest for this week’s episode is Maneesh Jain, CEO and Co-Founder of Mirvie, a life science company that predicts pregnancy complications before they happen by revealing the underlying biology of pregnancy health. Mirvie is dedicated to shaping the future of pregnancy health through simple, personalized blood tests. Before Mirvie, Maneesh was a founder, CEO, or executive of five successful start-ups, which include Parallele Bioscience, Auriphex Bioscience, Ion Torrent, Butterfly Network, and Cirina.
All of the businesses successfully exited or commercialized to the likes of Affymetrix, Illumina, Life Technologies, the FDA, and GRAIL, respectively. Join us as we sit down with Maneesh to talk about how his fundamental curiosity and perseverance have been a mainstay across his career.
Maneesh also discusses how he views entrepreneurship as a way to improve lives and make positive societal impacts. Lastly, we cover his time during undergrad and graduate school, how it led to spinning out ParAllele BioScience, and the many lessons its merger with Affymetrix provided. Please enjoy my conversation with Maneesh.
Find Our Guest, Maneesh Jain, at these links: https://www.linkedin.com/in/maneesh-jain-2509388/https://www.mirvie.com/ Find Our Host, Jon Chee, at these links: https://www.linkedin.com/in/joncheehttps://www.excedr.comSocial & WebsiteLinkedIn:
https://www.linkedin.com/company/excedr/ Youtube:
https://www.youtube.com/@excedr Instagram:
https://www.instagram.com/excedr_inc Twitter:
https://twitter.com/ExcedrInc Facebook:
https://www.facebook.com/excedr TikTok:
https://www.tiktok.com/@excedr Podcast Website:
https://www.thebiotechstartupspodcast.com/Timestamps: 00:00 Intro
02:20 Episode start, Maneesh’s fundamental curiosity and thirst for knowledge, the value of perseverance
04:43 Entrepreneurship as a way to improve people’s lives and make a societal impact, time at CalTech
07:02 Undergraduate lab experience, turning knowledge into practical applications, mentors
09:36 Graduate school at Stanford, taking big open-ended problems and breaking them down
12:17 Moving to a field that is going to have its “Magic Decade”, transitioning to life sciences
15:00 Benefits of being a “clean slate”, working at the Stanford Genome Technology Center
17:24 Finding a project to spin-out, ParAllele BioScience and finding co-founders
22:28 The importance of showing basic scalability, going through the merger with Affymetrix
26:30 Learning about product differentiation, understanding technology and market life cycles
29:50 Outro
Enriched Notes:Topics Mentioned:Entrepreneurship
https://www.excedr.com/category/entrepreneurshipLean Business Plan
https://www.excedr.com/resources/how-to-write-lean-business-planReducing Startup Costs & Expenses
https://www.excedr.com/blog/startup-costs-and-expenses CalTech
https://www.caltech.edu/ SURF
https://www.nist.gov/surf Biotech Accelerators
https://www.excedr.com/resources/biotech-acceleratorsAccelerator vs. Incubator
https://www.excedr.com/resources/accelerator-vs-incubator Human Genome Project
https://www.genome.gov/human-genome-project Stanford Genome Technology Center
https://med.stanford.edu/sgtc.html Computational Biology
https://en.wikipedia.org/wiki/Computational_biology ParAllele Bioscience
https://www.outsourcing-pharma.com/Article/2005/06/01/Affymetrix-acquires-ParAllele-BioScience Tech Transfer
https://www.excedr.com/blog/what-is-tech-transfer Spinning Out of Academia
https://www.excedr.com/resources/how-to-spin-out-of-academia-and-into-a-startup Do You Need a Co-founder
https://www.excedr.com/resources/do-you-need-a-co-founder-for-your-startup Error Bars
https://en.wikipedia.org/wiki/Error_bar Affymetrix
https://www.linkedin.com/company/affymetrix/ Illumina
https://www.illumina.com/ People Mentioned:Amnon Rariv
https://www.linkedin.com/in/amnon-yariv-12a75766/ Ron Davis
https://www.linkedin.com/in/ron-davis-56a34852/